Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Patent
1994-08-23
1998-02-10
Hutzell, Paula K.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
4241311, 4241391, 4241411, 4241451, 4241561, 514 12, 514866, A61K 39395, A61K 3800
Patent
active
057166196
ABSTRACT:
Antibody methods for blocking the effects of diabetes-associated peptide, or "amylin", a hormone found in the amyloid masses of Type 2 diabetics, are disclosed. This putative hormone has been discovered to function both to inhibit insulin secretion and to inhibit glycogen synthesis. Regulation is accomplished by blocking the binding of amylin or amylin agonists, including calcitonin gene related peptide (CGRP), or biologically active sub-peptides thereof. Inhibitors include antibodies directed to amylin and amylin agonist active sites. Other antagonists include anti-idiotype antibodies directed to antibodies directed to amylin.
REFERENCES:
patent: 4530839 (1985-07-01), Evans
patent: 4661586 (1987-04-01), Levy et al.
patent: 4687839 (1987-08-01), Kempe
patent: 4697002 (1987-09-01), Kempe
patent: 4720483 (1988-01-01), Janz
patent: 4736023 (1988-04-01), Evans
patent: 5266561 (1993-11-01), Cooper et al.
Foord et al., Eur. J. Biochem. 170:373 (1987).
Sewell et al., Soc. Neurosci. Abs. 13:42 (1987).
Kimura et al., Neuropeptides 9:75 (1987).
Minvielle et al., FEBS Lett. 203:7 (1986).
Morris et al., Nature 308:746 (1984).
Craig et al., Biochem. Soc. Symp. 52:91 (1986).
Tippins et al., J. Hypertens., 4:5102 (1986).
Tippins et al., Biochem. Biophys. Res. Commun., 134:1306 (1981).
Holman et al., Peptides, 7:231 (1986).
Lenz et al., Gut, 26:550 (1985).
Westermark et al., Biochem. Biophys. Res. Commun. 140:827 (1986).
Westermark et al., Diabetologia, 30:887 (1987).
Westermark, et al., Proc. Nat. Acad. Sci. (USA), 84:3881 (1987).
Westermark et al., Am. J. Pathol., 127:414 (1987).
Cooper et al., Proc. Nat. Acad. Sci. (USA) 84:8628 (1987).
Cooper et al., Lancet 2:966 (1987).
Goding (1983) "Monoclonal Antibodies, " Academic Press, Inc., Orlando, pp. 56-97.
Koike et al (1987) Diabetes 36:539-541.
Gregonadis et al (1993) Trends in Biotech. 11:440-442.
Leighton et al (1987) Nature 335:632-635.
Cooper Garth J.S.
Greene, Jr. Howard
Amylin Pharmaceuticals Inc.
Hutzell Paula K.
Prickril Benet
LandOfFree
Treatment of type 2 diabetes mellitus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of type 2 diabetes mellitus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of type 2 diabetes mellitus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2075026